Topic: hypertension

gilead

4. Letairis

Letairis is an endothelin receptor antagonist that was first approved in 2007 as a treatment for pulmonary arterial hypertension (PAH). In 2015, Letairis was approved to treat PAH when paired with tadalafil.
human heart

Special Report—The top 10 cardiovascular drugs in the world

Cardiovascular drugs may not be the top field in terms of sales or market growth rate. But heart disease and related ailments remain the biggest cause of death in the U.S. We’ve put together this list as a state-of-the-market snapshot, coinciding with the European Society of Cardiology meeting this week.